Digestive Diseases and Sciences

, Volume 59, Issue 10, pp 2514–2522 | Cite as

Effect of Follow-Up Endoscopy on the Outcomes of Patients with Inflammatory Bowel Disease

  • Duk Hwan Kim
  • Soo Jung Park
  • Jae Jun Park
  • Young Hoon Yun
  • Sung Pil Hong
  • Tae Il Kim
  • Won Ho Kim
  • Jae Hee Cheon
Original Article



Little is known about the role of follow-up endoscopy in patients with inflammatory bowel disease (IBD).


The present study aimed to evaluate whether repeated endoscopies would be beneficial in improving outcomes of patients with IBD.


Patients who had been initially confirmed to have IBD at two tertiary hospitals in Korea were regularly followed and included in this study. The clinical impact as assessed by the presence or absence of a change in management after endoscopy and cumulative hospitalization rate was compared between two groups classified according to the presence or absence of indications.


A total of 188 patients with IBD were enrolled [69 patients with Crohn’s disease (CD) and 119 with ulcerative colitis (UC)]. Of these patients, 130 underwent follow-up endoscopy (48 with CD and 82 with UC). The rate of management change was significantly higher in the group with indications for follow-up endoscopy (p = 0.001 in CD and <0.001 in UC). The presence of any indications for follow-up endoscopy was found to be a significant predictor of hospitalization risk in patients with UC (p = 0.015), but not in those with CD. However, there was no significant difference in cumulative hospitalization hazard with respect to treatment change in patients without any endoscopic indications (p = 0.561 in CD and 0.423 in UC).


Follow-up endoscopy might not have a significant impact on the overall clinical course and outcomes in patients with IBD. However, the presence of endoscopic indications predicts a poor clinical outcome in UC.


Inflammatory bowel disease Crohn’s disease Ulcerative colitis Colonoscopy Sigmoidoscopy 



This study was supported by a Grant (2013-E63004-00) from the Research of Korea Centers for Disease Control and Prevention and a Grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant Number A120176).

Conflict of interest



  1. 1.
    Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7–27.PubMedCrossRefGoogle Scholar
  2. 2.
    Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53:V1–V16.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Cheon JH, Kim WH. Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver. 2007;1:118–125.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Rutgeerts P, Feagan BG, Lichtenstein GR, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease. Gastroenterology. 2004;126:402–413.PubMedCrossRefGoogle Scholar
  5. 5.
    Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194–1201.PubMedCrossRefGoogle Scholar
  6. 6.
    Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371–1385.PubMedCrossRefGoogle Scholar
  7. 7.
    Leighton JA, Shen B, Baron TH, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63:558–565.PubMedCrossRefGoogle Scholar
  8. 8.
    Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–2729.PubMedCrossRefGoogle Scholar
  10. 10.
    Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.PubMedGoogle Scholar
  11. 11.
    Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412–422.PubMedCrossRefGoogle Scholar
  12. 12.
    Thakkar K, Lucia CJ, Ferry GD, et al. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease. Am J Gastroenterol. 2009;104:722–727.PubMedCrossRefGoogle Scholar
  13. 13.
    Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol. 2005;3:11–24.PubMedCrossRefGoogle Scholar
  14. 14.
    American Society for Gastrointestinal Endoscopy. Appropriate use of gastrointestinal endoscopy. Gastrointest Endosc. 2000;52:831–837.CrossRefGoogle Scholar
  15. 15.
    Hommes DW, van Deventer SJ. Endoscopy in inflammatory bowel diseases. Gastroenterology. 2004;126:1561–1573.PubMedCrossRefGoogle Scholar
  16. 16.
    Baars JE, Nuij VJ, Oldenburg B, et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis. 2012;18:1634–1640.PubMedCrossRefGoogle Scholar
  17. 17.
    Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology. 1987;92:181–185.PubMedGoogle Scholar
  18. 18.
    Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010;4:1–14.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007;56:453–455.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    D’Haens G, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: a European multicenter trial. Gastroenterology. 1999;116:1029–1034.PubMedCrossRefGoogle Scholar
  21. 21.
    Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis. 2009;15:1295–1301.PubMedCrossRefGoogle Scholar
  22. 22.
    Allez M, Lemann M. Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol. 2010;16:2626–2632.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    van Assche G, Vermeire S, Rutgeerts P. Mucosal healing and anti TNFs in IBD. Curr Drug Targets. 2010;11:227–233.PubMedCrossRefGoogle Scholar
  24. 24.
    Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619–1635.PubMedCrossRefGoogle Scholar
  25. 25.
    Pineton de Chambrun G, Peyrin-Biroulet L, Lemann M, et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010;7:15–29.PubMedCrossRefGoogle Scholar
  26. 26.
    Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease. Gastrointest Endosc. 2006;63:433–442; quiz 464.Google Scholar
  27. 27.
    Cooper HS, Raffensperger EC, Jonas L, et al. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology. 1977;72:1253–1256.PubMedGoogle Scholar
  28. 28.
    Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis. Am J Gastroenterol. 2001;96:773–775.PubMedCrossRefGoogle Scholar
  29. 29.
    Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1,116 patients. Dig Dis Sci. 1993;38:1137–1146.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Duk Hwan Kim
    • 1
  • Soo Jung Park
    • 1
  • Jae Jun Park
    • 2
  • Young Hoon Yun
    • 2
  • Sung Pil Hong
    • 1
  • Tae Il Kim
    • 1
    • 3
  • Won Ho Kim
    • 1
    • 3
  • Jae Hee Cheon
    • 1
    • 3
  1. 1.Department of Internal Medicine, Institute of GastroenterologyYonsei University College of MedicineSeoulKorea
  2. 2.Department of Internal Medicine, Gangnam Severance HospitalYonsei University College of MedicineSeoulKorea
  3. 3.Brain Korea 21 Project for Medical ScienceYonsei University College of MedicineSeoulKorea

Personalised recommendations